Scholars Central

Research articlePublished 3 May 2019

Antibacterial study of mixed ligand chelate and its application to tuberculosis

Authors: Chitra Rekha Tiwari

Der Pharma Chemica

Volume 4 · Issue 1 · Pages 39–42

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Rifampicin, anti-tubercular drugs have been screened for their activity towards mycobacteria, Ecoli and Streptocoli.On Mycobacerium bacteriological activity have been conducted With metal chelates (complexes) of Pyrazinamide, Isoniazid and Rifampicin the results obtained were compared with that of the Parent drug. It is being shown that in many cases metal complexes were more potent than as compared with pure drug. The study revels that few metal chelates (complexes) show a remarkable resistance as compared with the Parent drug.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharma Chemica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Chitra Rekha Tiwari”